F. Luzzaro et al., Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase, J CLIN MICR, 39(5), 2001, pp. 1865-1870
From November 1998 to August 1999, a large outbreak occurred in the general
intensive care unit of the Ospedale di Circolo in Varese (Italy), caused b
y Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta -lactam
ase. A total of 108 clinical isolates of P. aeruginosa resistant to broad-s
pectrum cephalosporins were recovered from 18 patients. Epidemic isolates w
ere characterized by synergy between clavulanic acid and ceftazidime, cefep
ime, and aztreonam. Isoelectric focusing of crude bacterial extracts detect
ed two nitrocefin-positive bands with pI values of 8.0 and 5.3. PCR amplifi
cation and characterization of the amplicons by restriction analysis and di
rect sequencing indicated that the epidemic isolates carried a bla(PER-1) d
eterminant. The outbreak was of clonal origin as shown by pulsed-field gel
electrophoresis analysis. This technique also indicated that the epidemic s
train was not related to three other PER-1-positive isolates obtained at th
e same hospital in 1997. Typing by enterobacterial repetitive intergenic co
nsensus-PCR showed that minor genetic variations occurred during the outbre
ak The epidemic strain was characterized by a multiple-drug-resistance phen
otype that remained unchanged over the outbreak, including extended-spectru
m cephalosporins, monobactams, aminoglycosides, and fluoroquinolones. Isola
tion of infected patients and appropriate carbapenem therapy were successfu
l in ending the outbreak Our report indicates that the bla(PER-1) resistanc
e determinant may become an emerging therapeutic problem in Europe.